| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/08/2008 | CA2285928C Allergen formulation comprising tyrosine and 3 de-o-acylated monophosphoryl lipid a |
| 07/08/2008 | CA2218884C Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 07/08/2008 | CA2209135C Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 07/08/2008 | CA2198706C Methods for the treatment of inflammatory joint disease |
| 07/08/2008 | CA2188029C Porphocyanine and cnc-expanded porphyrins |
| 07/08/2008 | CA2187329C Pharmaceutical formulations for treating dust mite allergy |
| 07/08/2008 | CA2186366C Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis |
| 07/08/2008 | CA2150262C Multivalent and multispecific binding proteins, their manufacture and use |
| 07/08/2008 | CA2148907C Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/08/2008 | CA2132836C Immunization by inoculation of dna transcription unit |
| 07/08/2008 | CA1341576C Diagnosis of retinoblastoma |
| 07/03/2008 | WO2008080091A2 Activation of rig-i pathway |
| 07/03/2008 | WO2008080045A2 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 07/03/2008 | WO2008079995A2 Conjugate of natriuretic peptide and antibody constant region |
| 07/03/2008 | WO2008079924A1 Immune response modifier compositions and methods |
| 07/03/2008 | WO2008079849A2 Antibodies to insulin-like growth factor receptor |
| 07/03/2008 | WO2008079732A2 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 07/03/2008 | WO2008079713A2 Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
| 07/03/2008 | WO2008079653A1 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 07/03/2008 | WO2008079539A2 Recombinant herpesvirus with diminished latency and methods of using same |
| 07/03/2008 | WO2008079466A1 Antibodies and methods for making and using them |
| 07/03/2008 | WO2008079361A2 Cxcl13 binding proteins |
| 07/03/2008 | WO2008079352A2 Antibodies to cd200r |
| 07/03/2008 | WO2008079326A2 Methods for using and identifying modulators of delta-like 4 |
| 07/03/2008 | WO2008079322A1 Methods, kits and materials for diagnosing disease states by measuring isoforms or proforms of myeloperoxidase |
| 07/03/2008 | WO2008079246A2 Cd44 antibodies |
| 07/03/2008 | WO2008079172A2 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof |
| 07/03/2008 | WO2008079095A1 Novel prostate kallikrein allergen |
| 07/03/2008 | WO2008078715A1 Therapeutic agent for inflammatory myopathy containing il-6 antagonist as active ingredient |
| 07/03/2008 | WO2008078673A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 07/03/2008 | WO2008078331A1 Medicinal formulation for the treatment for hepatitis c |
| 07/03/2008 | WO2008078177A2 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 07/03/2008 | WO2008078057A1 Protein complex and uses |
| 07/03/2008 | WO2008077546A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 07/03/2008 | WO2008077527A1 Rsv f-protein and use thereof |
| 07/03/2008 | WO2008077413A1 Dna vaccines for fish |
| 07/03/2008 | WO2008077356A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia |
| 07/03/2008 | WO2008077355A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 07/03/2008 | WO2008077171A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 07/03/2008 | WO2008058116A3 Tbpb proteins in attenuated oral live vaccines |
| 07/03/2008 | WO2008057329A9 Method for detecting and controlling cancer |
| 07/03/2008 | WO2008056174A3 Novel compositions and uses thereof |
| 07/03/2008 | WO2008051977A3 Methods of reducing phosphate absorption |
| 07/03/2008 | WO2008051186A3 Nanoemulsion containing compositions having ant i -inflammatory activity |
| 07/03/2008 | WO2008048945A3 Conjugates of plasmodium falciparum surface proteins as malaria vaccines |
| 07/03/2008 | WO2008036838A3 Isolated complexes of covalently cross-linked endotoxin and modified md-2 |
| 07/03/2008 | WO2008036337A8 Predicted phosphorylation sites |
| 07/03/2008 | WO2008036147A3 Drug delivery with stimulus responsive biopolymers |
| 07/03/2008 | WO2008032158A3 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 07/03/2008 | WO2008028957A3 Vaccine |
| 07/03/2008 | WO2008028667A3 Use of glycolipids as adjuvants |
| 07/03/2008 | WO2008027013A3 Combination of mtor antagonist and angiogenesis inhibitor for the treatment of cancer |
| 07/03/2008 | WO2008021156A3 Antibodies to il-17a |
| 07/03/2008 | WO2008017859A3 Ligand for the g6b receptor on blood platelets |
| 07/03/2008 | WO2008014386A3 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists |
| 07/03/2008 | WO2007149875A3 Compositions and methods for treating, preventing and/or reversing type-1 diabetes |
| 07/03/2008 | WO2007056642A3 Method for modulating inflammatory responses |
| 07/03/2008 | WO2006082530A3 Conjugation of streptococcal capsular saccharides to carrier proteins |
| 07/03/2008 | US20080161263 Fusion proteins of Mycobacterium tuberculosis |
| 07/03/2008 | US20080161255 Use of Parp Inhibitors for Prevention and Treatment of Diabetic and Insulin Resistance Complications |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161241 Preventing sustained monomorphic ventricular tachycardia following myocardial ischemia by administering etanercept; or bortezomib; inhibits substantial loss of beta-adrenergic receptor kinase (beta-ARK) activity |
| 07/03/2008 | US20080160606 Expression vector comprising nucleotide sequences coding toxoplasma major surface antigen p30 for use in generation of immunoglobulin for use in prevention and treatment of parasitic infection |
| 07/03/2008 | US20080160576 Anti-alphabeta3 humanized monoclonal antibodies |
| 07/03/2008 | US20080160089 Vaccine delivery compositions and methods of use |
| 07/03/2008 | US20080160060 administering locally a therapeutic amount of a Sost/Wise antagonist in conjunction with an osteoconductive biocompatible calcium salt scaffold; medical orthopedic or periodontal device; prevents kidney damage |
| 07/03/2008 | US20080160058 bait and uses thereof |
| 07/03/2008 | US20080160050 Dendritic cell tumor injection therapy and related vaccine |
| 07/03/2008 | US20080160049 Tissue Vaccines and Uses Thereof |
| 07/03/2008 | US20080160048 Comprising chimeric cytomegalo virus related promoter sequence and cloning site for insertion of coding sequence in operable linkage; particle mediated gene therapy and immunization |
| 07/03/2008 | US20080160047 Oil in water emulsions containing saponins |
| 07/03/2008 | US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 07/03/2008 | US20080160045 Vaccines Comprising Aluminum Adjuvants and Histidine |
| 07/03/2008 | US20080160044 Soy Peptone as a Nitrogen Source in Preparing Meningcoccal Conjugates |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160040 Using papillomavirus minor capsid protein as tool in generating neutralizing antibodies which prevent and treat papillomal infection |
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160038 Non-anaphylactic Forms of Grass Pollen Ph1 p 6 Allergen and Their Use |
| 07/03/2008 | US20080160037 Novel beta-defensins |
| 07/03/2008 | US20080160036 Protein fusion for use as antagonist to V-set domain containing T cell activation inhibitor 1(B7 H4); treating rheumatoid atrhritis, cardiomyopathy, skin, liver and connective tissue disorders |
| 07/03/2008 | US20080160035 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders |
| 07/03/2008 | US20080160034 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160032 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis |
| 07/03/2008 | US20080160031 Method and Composition for Treatment of Neoplasms |
| 07/03/2008 | US20080160030 Anti-Interferon Alpha Monoclonal Antibodies and Methods for Use |
| 07/03/2008 | US20080160029 Treatment with anti-vegf antibodies |
| 07/03/2008 | US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas |
| 07/03/2008 | US20080160027 Chlamydia pneumoniae vaccine and methods for administering such a vaccine |
| 07/03/2008 | US20080160026 Apo-2 ligand-anti-her-2 antibody synergism |
| 07/03/2008 | US20080160025 Glucocorticoid mixture for use in treatment and prevention of autoimmune, bone and skin disorders; tumor necrosis factor-immunoglobulin fusion for use in immnosuppressive therapy |
| 07/03/2008 | US20080160024 Inhibition of cancer metastasis |
| 07/03/2008 | US20080160023 Using type-1 peroxisomal targeting signal protein as tool in identifying modulators for prevention and treatment of heart ischemia, dietary obesity, fatty liver disease and hypercholesterolemia |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160021 Antagonist antibody or fragment that binds to a specific polypeptide, used for the treatment of a degenerative cartilaginous disorder, including osteo-, rheumatoid and psoriatic arthritis |
| 07/03/2008 | US20080160020 Methods For Reducing the Symptoms of Autoimmunity and Inflammation Using Binding Proteins Against Antigens Exposed on Dead or Dying Cells |
| 07/03/2008 | US20080160019 Using mixture comprising tyrosine kinase with immunoglobulin-like and EGF-like domains-1 (TIE-1)binding agent and endothelial growth factor antagonist to treat and prevent cell proliferative disorders |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160017 Cross-Linked Antibodies |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |